Brought to you by 
Pfizer, via CTI unit, partners with the NIH
08 Dec 2014
Executive Summary
Through its Centers for Therapeutic Innovation (CTI) academic partnership unit, Pfizer Inc. is aligning with the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) to identify and develop biologics.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pfizer, via CTI unit, partners with the NIH
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice